MustGrow Biologics Isolates Third Molecule From Mustard Plant

MustGrow Biologics (CSE: MGRO) continues to conduct research on the mustard plant and extract different molecules. The firm this morning announced that it has now isolated and concentrated thiocyanate, the third such molecule to be extracted from the plant.

Thiocyanate is reponsible for the systemic activity behind the mustard plants natural herbicidal properties. In layman terms, the molecule works to kill weeds, with the company having previously demonstrated proof of concept success without isolating the molecule. Those prior studies will now be built upon following the isolation of this molecule.

The extract reportedly has the potential of being a natural organic non-selective bioherbicide that is soil active and contains systemic translocated properties. As per the company, this is significant as “given that the leading synthetic herbicide glyphosate is not soil active, and only acts on the above ground parts of the weed it contacts.” The result is that it could either replace or compliment the use of glyphosate while being a natural and organic solution.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The company is now in the process of greenhouse testing the extract both on a stand-alone basis as well as in combination with the firms TerraMG product. The former is a non-selective bioherbicide, while the latter is a biopesticide used to control disease and pests.

MustGrow Biologics last traded at $1.95 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

A $2.2B Gold Project Is Outgrowing Its Plan | Michael Henrichsen – Gold X2 Mining

Pay for the Copper, Get the Gold Free | Rob McEwen – McEwen Inc

This Gold Discovery Was Already Huge. Now It’s Becoming a Monster. | Goliath Resources

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

MustGrow Secures Patent For Mustard-Based Sprout Suppressant

MustGrow Biologics (CSE: MGRO) is pushing forward with its focus on natural biopesticides, this morning...

Monday, November 23, 2020, 07:27:00 AM

MustGrow Biologics To Collaborate With Univar Solutions On Field Trials

MustGrow Biologics (CSE: MGRO) is progressing with field trials for its TerraMG product. The company...

Thursday, April 29, 2021, 08:02:05 AM

MustGrow Biologics Reports Positive Trial Results In Colombia

MustGrow Biologics (CSE: MGRO) this morning released further results from ongoing field trials being conducted...

Monday, July 12, 2021, 07:33:27 AM

MustGrow Announces 100% Control Of Root Rot Disease With Patented Biopesticide

MustGrow Biologics (CSE: MGRO) has seen further success with its mustard-derived biopesticide, this morning announcing...

Wednesday, January 20, 2021, 07:58:22 AM

MustGrow Sees Sumitomo Expand Development Program For Proprietary Tech

MustGrow Biologics (CSE: MGRO) has expanded its relationship with Japanese conglomerate Sumitomo Corporation. The firm...

Tuesday, December 14, 2021, 08:17:55 AM